Chronic obstructive pulmonary disease (COPD) is a common chronic respiratory disease primarily caused by long-term damage to the airways and lung tissue, leading to persistent airflow limitation. Patients often experience chronic cough, sputum production, shortness of breath, and decreased exercise capacity.

COPD is generally considered a lung disease, but as it progresses, its effects can also extend to the cardiovascular system. Long-term hypoxia, changes in lung structure, and increased pulmonary circulation pressure place a greater burden on the heart, especially the right ventricle. Simultaneously, COPD patients have a relatively higher risk of cardiovascular disease, including arrhythmias and myocardial ischemia. Therefore, in the long-term management of COPD patients, in addition to monitoring changes in lung function, attention must also be paid to cardiac health.

Electrocardiography (ECG) is a simple, rapid, non-invasive, and widely used examination method. During an ECG, leads are connected to electrodes and an ECG device to collect electrical signals from the patient's body surface, converting the heart's electrical activity into ECG waveforms that can be analyzed by a physician. While an electrocardiogram (ECG) cannot directly diagnose COPD or replace pulmonary function tests, it serves as an important auxiliary tool, helping doctors understand whether the disease has already affected the heart and promptly detect potential cardiovascular risks.

For some patients with moderate to severe COPD, long-term decline in lung function may increase the burden on the heart and affect its normal function. Due to abnormal lung inflation and changes in blood circulation pressure, ECG examinations sometimes reveal related abnormalities, such as weakened ECG signals and altered directions of cardiac electrical activity. During the examination, stable connection of the ECG leads is crucial for obtaining accurate ECG signals. As the disease progresses, some patients may exhibit ECG findings related to increased right ventricular load.

In addition to changes in cardiac load, COPD patients are also more prone to cardiac rhythm problems. Long-term hypoxia, changes in physical function, and the effects of some medications can all increase the risk of abnormal heart rhythms. For example, multifocal atrial tachycardia is a common arrhythmia in COPD patients, and atrial fibrillation is also an important issue that requires attention. In recent years, with the development of digital electrocardiogram (ECG) analysis technology, intelligent analysis methods based on ECG data have been increasingly used for risk assessment, helping to identify patients with potentially high cardiac arrhythmia risks and providing a reference for subsequent monitoring and treatment. In this process, high-quality signal acquisition relies on ECG monitoring equipment components, including ECG leads.

Another important value of ECG lies in helping doctors differentiate the different causes of respiratory symptoms. COPD patients often experience shortness of breath, chest tightness, and decreased activity levels, but these symptoms are not necessarily solely due to lung problems. Sometimes, heart disease can also present with similar symptoms. Through ECG examination, doctors can help determine whether there are cardiac factors such as arrhythmias and myocardial ischemia, thus enabling a more comprehensive assessment. Reliable ECG leads can help reduce signal interference, improve the stability of data acquisition during the examination, and support clinical judgment.

Studies show that COPD patients have a higher proportion of ECG abnormalities compared to non-COPD individuals, and some abnormalities are related to disease severity and prognosis. For example, abnormal resting heart rate, ischemic changes in ECG, and changes in certain ECG parameters may indicate a higher cardiovascular risk in patients. Therefore, ECG monitoring in appropriate populations can help detect changes in the condition earlier and support clinical decision-making.

It is important to emphasize that the core assessment of COPD still relies on pulmonary function tests, imaging studies, and clinical symptom assessment. ECG is not a diagnostic tool for COPD, but rather provides an important cardiovascular supplement in disease management. For patients with moderate to severe COPD, those experiencing acute symptom exacerbations, and those with coexisting cardiovascular risk factors, ECG monitoring helps healthcare professionals gain a more comprehensive understanding of the patient's overall health status. ECG leads, as an important component of the ECG monitoring system, will also play a crucial role in accurately obtaining the patient's ECG information.